Dianthus Therapeutics, Inc.

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 719000000 MR: - FA: 719 million FAN: 719000000	D: 2026-03-12 FD: 2026-03-12	7 investors
2	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 625000000 MR: - FA: $625 million FAN: 625000000	D: 2026-03-10 FD: 2026-03-10	7 investors
3	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 400000000 MR: - FA: $400 million FAN: 400000000	D: 2026-03-09 FD: 2026-03-09	7 investors
4	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 288000000 MR: - FA: 288 million FAN: 288000000	D: 2025-09-11 FD: 2025-09-11	5 investors
5	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 251000000 MR: - FA: approximately $251 million FAN: 251000000	D: 2025-09-09 FD: 2025-09-09	5 investors
6	RT: PIPE T: - FT: PIPE	A: 230000000 MR: - FA: 230 million FAN: 230000000	D: 2024-01-22 FD: 2024-01-22	17 investors

Public Offering Latest

2026-03-12

$719.0M

7 investors (Pro only)

Underwritten Public Offering 2026-03-10

$625.0M

Underwritten Public Offering 2026-03-09

$400.0M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Marino Garcia

President & Chief Executive Officer, Board Member

LinkedIn (Pro only)

S

Simrat Randhawa

Chief Medical Officer

LinkedIn (Pro only)

R

Ryan Savitz

Chief Financial Officer & Chief Business Officer

LinkedIn (Pro only)

J

John King

Chief Commercial Officer

A

Adam Veness

General Counsel

K

Kristina Maximenko

Chief People Officer

View 13 more team members with Pro

Unlock Full Team Directory

Recent News